Main Catalog

Found 87
Sort by
AMCP Annual Meeting
Member Free
Non-Member $30.00

Patient Review and Restriction Programs: Prescription Drug Monitoring Programs and the Need for Collaboration

Contact Hours: 1.25. Patient Review and Restriction (PRR) programs are commonly used by health plans in doctor’s offices to manage the excessive prescribing of controlled substances or services.
Hospital/Health Systems
Nexus Conferences
Member Free
Non-Member $30.00

Payer & Manufacturer Communications: What’s Changed & How Does it Impact Managed Care Pharmacy? - Nexus 2017

Contact Hours: 1.5. FDA released long-awaited draft guidance clarifying the Provisions of FDAMA 114 as updated by Cures 3037, and also outlined its current thinking around preapproval information exchange (PIE).
CMS
AMCP Annual Meeting
Member $15.00
Non-Member $30.00

Perspectives in Gene Therapy Management - Annual Meeting 2019

Contact Hours: 1.0. The potential for gene therapy to transform the treatment of a wide variety of health conditions has important implications for many stakeholders.
Gene Therapy
AMCP Annual Meeting
Member $15.00
Non-Member $30.00

Perspectives in Hemophilia Management - Annual Meeting 2018

Contact Hours: 1.0. The treatment of hemophilia has evolved from a one-size-fits-all approach to a highly individualized care approach, and it continues to become more
patient-centered and specific.
Hemophilia
Webinars
Member Free
Non-Member $30.00

Placing Potential Cures Within Reach: Real-World Experience and Evolving Management Home Study

Contact Hours: 1.0. A prominent health care payer and pharmacy benefit manager (PBM) will share their real-world experiences and learnings in managing innovative and expensive gene therapies.
AMCP eLearning Days Potential Cures
Nexus Conferences
Member $15.00
Non-Member $30.00

Preventative Treatment for Alzheimer’s Disease and the Future Role of Value-Based Payment Arrangements

Contact Hours: 1.5. The current understanding of Alzheimer’s disease is evolving.
Alzheimer's
AMCP Annual Meeting
Member Free
Non-Member $30.00

Pulmonary Arterial Hypertension and the Managed Care Considerations for Formulary Decision-Making

Contact Hours: 1.25. Patients with pulmonary arterial hypertension (PAH) currently have a 60% five-year survival outlook, which has been increasing since the 1980s when it was a 37% five-year outlook.
Pulmonary Arterial Hypertension
Nexus Conferences
Member Free
Non-Member $30.00

Rare Disease Therapies: Management Strategies to Pipeline Implications for Health Plans - Nexus 2017

Contact Hours: 1.5. The drug pipeline contains over 560 therapies in development for rare diseases.
Orphan Disease
Nexus Conferences
Member $15.00
Non-Member $30.00

Real-Time Pharmacy Benefits: Results and Learnings from a Real-World Implementation

Contact Hours: 1.5. Real-time pharmacy benefits (RTPB) deliver real-time access to medication pricing and restriction information at the point of prescribing.
Real-TIme Pharmacy
AMCP Annual Meeting
Member Free
Non-Member $30.00

Real-World Experience Managing Orphan Drugs Across Pharmacy and Medical Benefits

Contact Hours: 1.25. Recently approved drugs for orphan diseases have annual costs ranging from $90,000 to over $1 million, while also having variable value propositions.
Orphan Disease